Literature DB >> 19225004

Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice.

Yumiko Matsuoka1, David E Swayne, Colleen Thomas, Marie-Anne Rameix-Welti, Nadia Naffakh, Christine Warnes, Melanie Altholtz, Ruben Donis, Kanta Subbarao.   

Abstract

Following circulation of avian influenza H5 and H7 viruses in poultry, the hemagglutinin (HA) can acquire additional glycosylation sites, and the neuraminidase (NA) stalk becomes shorter. We investigated whether these features play a role in the pathogenesis of infection in mammalian hosts. From 1996 to 2007, H5N1 viruses with a short NA stalk have become widespread in several avian species. Compared to viruses with a long-stalk NA, viruses with a short-stalk NA showed a decreased capacity to elute from red blood cells and an increased virulence in mice, but not in chickens. The presence of additional HA glycosylation sites had less of an effect on virulence than did NA stalk length. The short-stalk NA of H5N1 viruses circulating in Asia may contribute to virulence in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225004      PMCID: PMC2668507          DOI: 10.1128/JVI.01987-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Additional glycosylation at the receptor binding site of the hemagglutinin (HA) for H5 and H7 viruses may be an adaptation to poultry hosts, but does it influence pathogenicity?

Authors:  J Banks; L Plowright
Journal:  Avian Dis       Date:  2003       Impact factor: 1.577

2.  Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture.

Authors:  S J Baigent; J W McCauley
Journal:  Virus Res       Date:  2001-11-05       Impact factor: 3.303

3.  Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir.

Authors:  Michael Z Wang; Chun Y Tai; Dirk B Mendel
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

Authors:  Hualan Chen; Kanta Subbarao; David Swayne; Qi Chen; Xiuhua Lu; Jacqueline Katz; Nancy Cox; Yumiko Matsuoka
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

5.  Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics.

Authors:  R Wagner; T Wolff; A Herwig; S Pleschka; H D Klenk
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.

Authors:  Yasuhiro Abe; Emi Takashita; Kanetsu Sugawara; Yoko Matsuzaki; Yasushi Muraki; Seiji Hongo
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes.

Authors:  Erica Spackman; Dennis A Senne; T J Myers; Leslie L Bulaga; Lindsey P Garber; Michael L Perdue; Kenton Lohman; Luke T Daum; David L Suarez
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

Authors:  J A L Ives; J A Carr; D B Mendel; C Y Tai; R Lambkin; L Kelly; J S Oxford; F G Hayden; N A Roberts
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

9.  A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody.

Authors:  J J Skehel; D J Stevens; R S Daniels; A R Douglas; M Knossow; I A Wilson; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice.

Authors:  Hualan Chen; Rick A Bright; Kanta Subbarao; Catherine Smith; Nancy J Cox; Jacqueline M Katz; Yumiko Matsuoka
Journal:  Virus Res       Date:  2007-05-22       Impact factor: 3.303

View more
  109 in total

Review 1.  The contribution of animal models to the understanding of the host range and virulence of influenza A viruses.

Authors:  Christopher D O'Donnell; Kanta Subbarao
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

2.  Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development.

Authors:  Mariette F Ducatez; Justin Bahl; Yolanda Griffin; Evelyn Stigger-Rosser; John Franks; Subrata Barman; Dhanasekaran Vijaykrishna; Ashley Webb; Yi Guan; Robert G Webster; Gavin J D Smith; Richard J Webby
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 3.  The Interaction between Respiratory Pathogens and Mucus.

Authors:  Mark Zanin; Pradyumna Baviskar; Robert Webster; Richard Webby
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

4.  Deadly H7N9 influenza virus: a pandemic in the making or a warning lesson?

Authors:  Robert A Lamb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

5.  Changes in the Length of the Neuraminidase Stalk Region Impact H7N9 Virulence in Mice.

Authors:  Yuhai Bi; Haixia Xiao; Quanjiao Chen; Yan Wu; Lifeng Fu; Chuansong Quan; Gary Wong; Jun Liu; Joel Haywood; Yingxia Liu; Boping Zhou; Jinghua Yan; Wenjun Liu; George F Gao
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

6.  Length variations in the NA stalk of an H7N1 influenza virus have opposite effects on viral excretion in chickens and ducks.

Authors:  T W Hoffmann; S Munier; T Larcher; D Soubieux; M Ledevin; E Esnault; A Tourdes; G Croville; J-L Guérin; P Quéré; R Volmer; N Naffakh; D Marc
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

7.  Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission.

Authors:  Sander Herfst; Salin Chutinimitkul; Jianqiang Ye; Emmie de Wit; Vincent J Munster; Eefje J A Schrauwen; Theo M Bestebroer; Marcel Jonges; Adam Meijer; Marion Koopmans; Guus F Rimmelzwaan; Albert D M E Osterhaus; Daniel R Perez; Ron A M Fouchier
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

8.  Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses.

Authors:  Gabriele Neumann; Catherine A Macken; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 9.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

10.  A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickens.

Authors:  S Munier; T Larcher; F Cormier-Aline; D Soubieux; B Su; L Guigand; B Labrosse; Y Cherel; P Quéré; D Marc; N Naffakh
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.